Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Biochemistry

Referred Work (108)

Blood Sciences - Biochemistry referred work. These tests are available via the standard electronic and paper request cards. Site specific processing will be detailed in the test information. These tests are referred to other laboratories for analysis.
Referred Work

Solihull Biochemistry Laboratory (2)

Solihull Blood Sciences - Biochemistry - Test menu. These tests are available routinely on the Solihull Hospital site and/or may required site specific sample processing. All other biochemistry tests are available, but site specific processing may be required. This section details those tests
Solihull Biochemistry Laboratory

Heartlands Biochemistry Laboratory (27)

Heartlands Blood Sciences - Biochemistry - Test menu. These tests are available routinely on the Heartlands site and/or may required site specific sample processing. All other biochemistry tests are available, but site specific processing may be required. This section details those tests
Heartlands Biochemistry Laboratory

Good Hope Biochemistry Laboratory (2)

Good Hope Blood Sciences - Biochemistry - Test menu. These tests are available routinely on the Good Hope site and/or may required site specific sample processing. All other biochemistry tests are available, but site specific processing may be required. This section details those tests
Good Hope Biochemistry Laboratory
Inhibin A

Inhibin A

Female range - post menopausal 0 - 3.6 pg/mL.

Values in the premenopausal female vary with the stage of cycle 5 - 160 pg/mL.

Male range - 0 - 3.6 pg/mL.

Reference ranges established by manufacturer and validated in-house.

Inhibin B

Inhibin B

Inhibin B reference ranges

Adult male:25-325 ng/L
Adult female:<341 ng/L
Post-menopause:<5 ng/L

Values in premenopausal women vary with the stage of cycle, with maximal values beting seen five to ten days after the LH surge.

HRT will artificially stimulate inhibin B production in the menopause.

 

Insulin

Insulin

No associated reference range. Should be interpreted alongside with glucose and c-peptide.

Non- diabetic hypoglycaemia
Evaluation of hypoglycaemia should only be undertaken for patients in whom Whipple’s triad has been documented. Firstly, review the history and physical findings to exclude more common hypoglycaemic aetiologies such as; drugs (insulin, insulin secretagogues, alcohol ingestion), critical illness (sepsis, organ failure), cortisol deficiency and non-islet cell tumours.
Once these have been excluded, in the seemingly well individual, the differentials lie between accidental/ surreptitious hypoglycaemia and endogenous hyperinsulinaemia. Further evaluation is warranted and should involve the following concomitant tests in the event of an ongoing episode of hypoglycaemia; plasma glucose (for confirmation of hypoglycaemia), insulin, C-peptide, beta-hydroxybutyrate as well as the measurement of circulating oral hypoglycaemic agents (if there is a degree of suspicion). When spontaneous hypoglycaemia cannot be observed, a prolonged fast or mixed meal test may recreate the environment in which hypoglycaemia is likely to occur.

Table 1: Taken from the Endocrine Society Guideline in 2009

Sxs/Signs

Glucose

(mmol/L)

Insulin (pmol/L) C-peptide (pmol/L) BHB (mmol/L) Circulating OHA Ab to insulin Interpretation
No <3.1 <21 <200 >2.7 No No Normal
Yes <3.1 >>21 <200 ≤2.7 No Neg (Pos) Exogenous insulin
Yes <3.1 ≥21 ≥200 ≤2.7 No Neg Insulinoma, NIPHS, PGBH
Yes <3.1 ≥21 ≥200 ≤2.7 Yes Neg Oral hypoglycaemic agent
Yes <3.1 >>21 >>200 ≤2.7 No Pos Oral hypoglycaemic agent
Yes <3.1 <21 <200 ≤2.7 No Neg IGF mediated
Yes <3.1 <21 <200 >2.7 No Neg Not insulin (or IGF) mediated

 

Iron (Serum)

Iron (Serum)

11.6-31.3 µmol/L(Males)

9.0-30.4 µmol/L(Females)


 The concentration of Iron in serum and plasma is dependent upon diet and is subject to circadian variations. Total iron may be slightly lower in the female population

From 06.07.2020, transferrin measurement has replaced UIBC measurement in the iron profile.

Lactate

Lactate

<16yrs   0.6-2.5 mmol/L    (Source : Pathology Harmony Recommendations)

Adult      0.5-2.2 mmol/L   (Source : Abbott Diagnostics)

CSF lactate-age related: 1.1-6.7mmol/L (neonates) 1.1-2.4 mmol/L (adults) 

Lactate Dehydrogenase (LDH)

Lactate Dehydrogenase (LDH)

125-220 IU/L (Enzyme activity not reported on haemolysed samples)

Source : Abbott Diagnostics

Laxative Screen

Interpretation advice from referral laboratory

Lipoprotein a (Lp (a))

Lipoprotein a (Lp (a))

Increased coronary risk over 75 nmol/L.

Lipoprotein X (LpX)

Lipoprotein X (LpX)

Provided by referral laboratory

Lipoprotein/lipid Electrophoresis (Serum)

Lipoprotein/lipid Electrophoresis (Serum)

None Given. Written report given.

PLEASE NOTE from 01/08/2012 lipoprotein electrophoresis is no longer performed in-house, specimens to be sent to referral laboratory.  All requests for lipoprotein electrophoresis to be vetted by Duty Biochemist.

Lithium

Lithium

0.4-1.0 mmol/L

(Source : Pathology Harmony Recommendations)

Ideally aim for 0.5 -0.8 mmol/L for maintainence/elderly patients and up to 1.2 mmol/L in acute mania.  The BNF states a therapeutic range of 0.4 to 1.0 mmol/L 12 hours post dose.

Luteinising Hormone (LH)

Luteinising Hormone (LH)

Males: 0.57 - 12.07 IU/L

Females

Follicular phase: 1.80 - 11.78 IU/L
Luteal phase: 0.56 - 14.0 IU/L
Mid Cycle: 7.59 - 89.08 IU/L
Post menopausal: 5.16 - 61.99 IU/L

Lysosomal Storage Disorders Testing

Lysosomal Storage Disorders Testing

Provided by Reference Laboratory

Macroprolactin Screening Test

Macroprolactin Screening Test

Reference ranges for Monomeric Prolactin are as follows:

Male:      32-309 mIU/L

Female:  39-422 mIU/L

<<  3 4 5 6 7 [89 10 11 12  >>